Trial Profile
A Phase 1 Clinical Study to Evaluate the Safety of Allogeneic Adipose-derived Stem Cells in the Subjects With Deep Second-degree Burn Wound
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Adipose stem cell therapy Anterogen (Primary)
- Indications Burns
- Focus Adverse reactions
- Sponsors Anterogen
- 29 Dec 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 24 Mar 2015 New trial record